Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy Regardless of PD-L1 Status in a Specific Type of Lung Cancer in Phase III Study
Go back to Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy Regardless of PD-L1 Status in a Specific Type of Lung Cancer in Phase III Study| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 55.44 +0.14 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.30 | 52 Week High | $35.13 | |||
| Open | $54.97 | 52 Week Low | $28.10 | |||
| Day High | $55.58 | P/E | N/A | |||
| Day Low | $54.68 | EPS | $0.00 | |||
| Volume | 1,313,369 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| ROGERS CORPORATION (NYSE: ROG) | Delayed: 135.77 +5.92 (4.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $129.85 | 52 Week High | $76.55 | |||
| Open | $130.50 | 52 Week Low | $41.92 | |||
| Day High | $136.98 | P/E | 76.71 | |||
| Day Low | $129.40 | EPS | $1.77 | |||
| Volume | 169,858 | |||||
